CHFR and breast carcinoma: Moreover, we analyzed 177 mesenchymal subtype breast cancer patients with systematic treatment including conventional chemotherapy and found that low expression of CHFR confers mesenchymal breast cancers resistant to chemotherapy [34] (Fig. S6; P = 0.029).